Divisions run deep over how to regulate stem cell clinics
CNN: Insoo Hyun, associate professor of bioethics, discussed the Federal Drug Administration’s recent hearing on how to regulate stem cell clinics. "To be clear, what the hearing is about is feedback on guidelines that are being proposed by the FDA, and these are not binding regulations; they are just points to consider," he said.
